 Lowell Smith Sr. Director, Business & Communication Research Administration Moffitt Cancer Center  Jeanine Stiles Chief Administrative Officer Associate Director for Administration UC Davis Comprehensive Cancer Center  Deidre B. Pereira, PhD Associate Professor Department of Clinical and Health Psychology College of Public Health and Health Professions University of Florida  Open Discussion

 Distress Screening - identify psychosocial symptoms (e.g., depression, anxiety) to determine needs and offer appropriate levels of psychosocial care  Survivorship - management of potential long-term and/or late effects of cancer and its treatment  Quality of life - an assessment of a patient’s well-being or lack thereof including all emotional, social, and physical aspects of the individual's life

 Growing national interest and emphasis in area(s)  Clinical & research areas include:  Patient and family centered care  Cancer care delivery research  Health Care Reform  Search for cost savings  Precision medicine  Emphasis on better outcomes  Funding opportunities  Patient-Centered Outcomes Research Institute (PCORI)  ~$650M a year in funding  Not limited to oncology  Competitive

 How is research area organized at your Center?  A research program by itself?  Is it an aim?  Subset of an aim/focus?  How integrated are your clinical and research areas?  Recruitment - how challenging?  Training  how formal is training and education in this research area?  R25/T32s?  How has the Affordable Care Act impacted the research?  Funding  Has the advent of PCORI funding impacted priorities for these program(s)?  Are there other funding sources besides PCORI?  Has anyone included distress screening or survivorship as research in the community?  Others thoughts?  Relationship between Clinical and Research Efforts  Role of External Advisory Committee and other advisory groups

 Structure  American College of Surgeons accredited  Clinical – 2 separate departments  Research – Integrated into one program (& department)  Administration – Patient & Family Services Department  Longstanding research in the area  Growing emphasis on Cancer Care Delivery

 Clinical and Academic Department  Includes  Behavioral medicine  Palliative care  Integrative Medicine  10 physicians including Chair  About half involved in research  Currently no CCSG Members

 Clinical and Academic Department  Includes  Senior Adult Oncology (clinical program)  Moffitt's Direct Referral Center (DRC) provides urgent care  10 physicians including Chair  Less than half involved in research  Currently 1 CCSG Member

 Academic Department  Research Program  21 CCSG Members including Program Leader  $5.8M current annual direct funding  Rated “Exceptional” last CCSG review (2011)  Involves research across the disease spectrum – from initiation, to detection, to treatment, and final outcomes  Aims 1. To understand the determinants of behaviors that can lead to prevention and early detection of cancer and develop effective methods of promoting those behaviors; 2. To understand and improve the quality of life (QOL) of patients and family members throughout the disease course; 3. To synthesize existing evidence and examine delivery of health services in order to improve the quality of cancer care; and 4. To understand and intervene upon the social, cultural, and behavioral determinants of cancer-related health disparities.

 PCORI  “Navigator Guided e-Psychoeducational Intervention for Prostate Cancer Patients and their Caregivers” (Rivers)  ACS  “Self-Administered Stress Management for Latinas Receiving Chemotherapy” (RSG, Jacobsen)  “Behavioral and EmotioNal Impact of BRCA Testing in African Americans (BENITA)” (RSG, Vadaparampil)  NCI  “HRQoL Values for Cancer Survivors: Enhancing PROMIS Measures for CER” (R01, Craig)  “Behavioral Oncology Education & Career Development” (R25, Jacobsen)  “Internet-Assisted Cognitive Behavior Intervention for Targeted Therapy Fatigue” (R21, Jacobsen)  “Sickness Behaviors During Chemotherapy for Gynecologic Cancer” (R01, Jim)

 Clinical setting vital for research  Collaboration important, but  Stick to stringent membership guidelines  Strong aim(s) can exist without physician-scientists on CCSG  Future plans rely on expanding this area  Lots of competition for expertise  Unlikely to develop into its own program  New funding opportunities  PCORI, like NCI, is very competitive

 How is research area organized at your Center?  A research program by itself?  Is it an aim?  Subset of an aim/focus?  How integrated are your clinical and research areas?  Recruitment - how challenging?  Training  how formal is training and education in this research area?  R25/T32s?  How has the Affordable Care Act impacted the research?  Funding  Has the advent of PCORI funding impacted priorities for these program(s)?  Are there other funding sources besides PCORI?  Has anyone included distress screening or survivorship as research in the community?  Others thoughts?  Relationship between Clinical and Research Efforts  Role of External Advisory Committee and other advisory groups